e-therapeutics (ETX) News Today → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free ETX Stock Alerts GBX 9 -0.18 (-1.91%) (As of 03:22 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineE-therapeutics Share Chatlse.co.uk - April 20 at 8:14 PMe-therapeutics (LON:ETX) Shares Cross Below 200-Day Moving Average of $11.94americanbankingnews.com - April 18 at 3:24 AMEliem Therapeutics to buy Tenet, announces $120 million private placementmsn.com - April 11 at 9:28 AMAquestive Therapeutics: Positive Phase III Data Unlocks Additional Catalysts For 2024seekingalpha.com - April 10 at 2:28 PMe-Therapeutics says company faces lack of interest as UK listinglse.co.uk - April 10 at 2:28 PMe-Therapeutics Shares Fall on London Delisting Plan; Mulls Move to New Yorkmarketwatch.com - April 10 at 2:28 PM‘Lack of appetite’ in London drives another high-tech firm to Nasdaqmsn.com - April 10 at 9:28 AMDrug discovery firm e-therapeutics to quit London Stock Exchange following £29m fundraisemsn.com - April 10 at 9:28 AMe-therapeutics (LON:ETX) Stock Passes Below 200 Day Moving Average of $12.11marketbeat.com - April 2 at 3:19 AMAquestive maps out FDA approval for sublingual anaphylaxis drugmsn.com - March 16 at 12:40 AMe-therapeutics (LON:ETX) Stock Price Crosses Below Two Hundred Day Moving Average of $12.41marketbeat.com - March 15 at 5:22 AMe-therapeutics (LON:ETX) Shares Pass Below 200-Day Moving Average of $12.52marketbeat.com - March 7 at 4:12 AMWe're Hopeful That e-therapeutics (LON:ETX) Will Use Its Cash Wiselyfinance.yahoo.com - January 3 at 7:29 AMMedical innovator e-therapeutics to stop trading on US-based marketmsn.com - December 27 at 8:10 AMEdison issues update on e-therapeutics (ETX): More to come in RNAi therapy discoverymarkets.businessinsider.com - November 13 at 5:53 AMEvecxia Therapeutics Strengthens Board of Directors With Appointments of Allan L. Shaw and Elliot Ehrichbusinesswire.com - October 30 at 11:43 AME-therapeutics bolsters generative AI integration and strategic...proactiveinvestors.com - October 26 at 8:02 AMU.S. FDA Partial Clinical Hold Lifted on IND for EryDel's Lead Phase 3 Asset EryDex for the Treatment of Ataxia-Telangiectasiabenzinga.com - September 28 at 5:01 PMQuince Therapeutics to Advance Study of EryDex as FDA Lifts Application Holdmarketwatch.com - September 28 at 5:01 PMe-therapeutics appoints new CFOproactiveinvestors.com - September 20 at 9:53 AMETX.L - e-Therapeutics plcuk.finance.yahoo.com - July 13 at 8:22 AMElicio Therapeutics Inc.wsj.com - June 8 at 1:08 PMAgeX Therapeutics Announces Appeal of NYSE American Determinationbusinesswire.com - May 23 at 7:55 PMRapid Dose Therapeutics Launches QuickStrip™ Dental Products in the Canadian Marketbusinesswire.com - May 10 at 8:36 PMDelix Therapeutics Initiates Phase I Trial for Novel Compound DLX-001marketwatch.com - May 10 at 1:30 AMAcute Renal Failure Therapeutics Market Located Worldwide Trends and Application – Baxter,Teva Pharmaceutical,Pfizermarketwatch.com - May 6 at 10:54 PME-Therapeutics FY 2023 Pretax Loss Widened on Higher R&D Costsmarketwatch.com - May 4 at 9:09 AMe-Therapeutics working to capitalise on AI "blindside"finance.yahoo.com - May 4 at 9:09 AMRelief Therapeutics Announces Results of Extraordinary General Meeting of Shareholdersmarkets.businessinsider.com - April 28 at 3:05 PM8-K: Seres Therapeutics, Inc.marketwatch.com - April 28 at 12:57 AMAquestive Therapeutics Expands License and Supply Agreement with Pharmanovia for Libervant(TM) (diazepam) Buccal Film to Additional Global Marketsmarketwatch.com - March 30 at 1:35 AMe-Therapeutics plc (ETX.L)uk.finance.yahoo.com - February 26 at 11:25 PMAkero Therapeutics Stock (NASDAQ:AKRO), Quotes and News Summarybenzinga.com - January 5 at 7:59 AMAkero Therapeutics Announces Breakthrough Therapy Designation For Efruxiferminmarkets.businessinsider.com - December 8 at 9:14 AMe-therapeutics raises £13.5mln via a direct subscription by funds run by M&Gproactiveinvestors.com - September 30 at 7:24 AMe-therapeutics: Fundraise of £13.5 millionfinance.yahoo.com - September 30 at 7:24 AMEmergence Therapeutics Licenses Synaffix ADC Technology Platform in $360M Dealfinance.yahoo.com - September 6 at 7:13 AMWHO recommends monoclonal antibody treatments for Ebola diseasemsn.com - August 21 at 1:24 AMCompanies Like e-therapeutics (LON:ETX) Are In A Position To Invest In Growthfinance.yahoo.com - August 4 at 4:04 AMEureka Therapeutics Announces Publication of Crystal Structure of TCR Mimic Redirected T Cells Targeting Alpha-Fetoprotein (AFP) for Liver Cancerfinance.yahoo.com - August 3 at 12:52 PMQuite a few insiders invested in e-therapeutics plc (LON:ETX) last year which is positive news for shareholdersfinance.yahoo.com - June 5 at 8:42 AMUnited Therapeutics Announces FDA Approval of Tyvaso DPI™benzinga.com - May 24 at 6:32 AMRelief Therapeutics to Participate in Industry and Investor Conferences in Mayyahoo.com - May 9 at 3:29 AMSee Here Why Recently Listed Eliem Therapeutics Shares Are Plummetingmsn.com - April 26 at 9:52 AMe-therapeutics achieves milestone in Galapagos collaborationproactiveinvestors.com.au - April 13 at 3:30 AMe-therapeutics teams up with US group iTeos Therapeutics to discover potential new cancer treatmentsproactiveinvestors.com - April 5 at 8:51 AMWe're Not Very Worried About e-therapeutics' (LON:ETX) Cash Burn Ratefinance.yahoo.com - February 25 at 3:54 AMELYM.OQ - Eliem Therapeutics Inc Profile | Reutersreuters.com - January 13 at 12:46 AMMultiple insiders bought e-therapeutics plc (LON:ETX) stock earlier this year, a positive sign for shareholdersfinance.yahoo.com - December 27 at 6:53 AMSMALL CAP MOVERS: Bens Creek soars; IG Design slumpsmsn.com - October 30 at 8:38 PM Get e-therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ETX and its competitors with MarketBeat's FREE daily newsletter. Email Address How to camouflage a factory of 53,000 workers (Ad)"If I Had To Pour Every Single Penny of My Retirement Into Just ONE STOCK..." The former Goldman Sachs VP – who called everything from Microsoft's 1,100% surge... to the death of the 60/40 portfolio – is now stepping forward with his most explicit message yet: "Make this ONE STOCK the cornerstone of your portfolio." Get the full story here. ETX Media Mentions By Week ETX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ETX News Sentiment▼0.670.44▲Average Medical News Sentiment ETX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ETX Articles This Week▼10▲ETX Articles Average Week Get e-therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ETX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: POLB News AREC News REDX News SAR News OKYO News C4XD News HEMO News DEST News OBD News ONC News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:ETX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersNew Trump BombshellThe Freeport SocietyMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding e-therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
